EGFR c.161_162delinsGC ;(p.M54S)

Variant ID: 7-55210051-TG-GC

NM_005228.3(EGFR):c.161_162delinsGC;(p.M54S)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity.

Nature Communications
Qiao, Yunqian Y; Qiu, Yangmin Y; Ding, Jie J; Luo, Nana N; Wang, Hao H; Ling, Xiaomin X; Sun, Jiya J; Wu, Zhihai Z; Wang, Yisen Y; Liu, Yanpeng Y; Guo, Feifei F; Sun, Ta T; Shen, Wanwan W; Zhang, Min M; Wu, Dongdong D; Chen, Bingliang B; Xu, Wei W; Wang, Xuan X
Publication Date: 2021-11-04

Variant appearance in text: EGFR: M54S
PubMed Link: 34737267
Variant Present in the following documents:
  • 41467_2021_Article_26645.pdf
View BVdb publication page